FLVCR2 and cancer: As CCT binds to gelsolin and possibly acts as a sequesterer for the Ca2+-bound active form (Brackley and Grantham 2011; Svanstrom and Grantham 2016), this interaction may be relevant for the effects of gelsolin on cancer progression.